We investigated risk factors for central nervous disease. In multivariate modeling, CNS involvement was strongly associated with cutaneous vasculitic system (CNS) involvement in systemic lupus erythematosus (SLE), in 32 such patients individually lesions OR 33, 95% CI 1.5-720) and arterial thromboses (OR 13, 95%CI 0.82-220), and negatively matched 153 to 96 control SLE patients without CNS events. Univariate analysis showed that CNS related to the presence of articular manifestations (OR 0.015, 95%CI 0.00-0.17) and discoid rash (OR involvement was significantly associated with the antiphospholipid syndrome (APS) as well as its fea-0.004, 95%CI 0.00-0.35). Associations with APSrelated arterial thromboses and vasculitis point to tures: arterial thrombosis, recurrent fetal loss, livedo reticularis and IgG anticardiolipin (aCL) antibodies the importance of arterial vascular pathophysiology in the pathogenesis of NP disease in SLE. Patients in high titres. Other potential associations included cutaneous vasculitic lesions, thrombocytopenia, poswith articular manifestations and discoid rash are at very low risk of NP events. Patients with an itive ANA, anti-SS-B/La and low serum levels of C 3 and C 4 complement components, while articular adverse SLE disease profile may require closer observation and may be the target group for studying manifestations and discoid rash were significantly less common in patients with neuropsychiatric (NP) pre-emptive interventions.
Introduction
Systemic lupus erythematosus (SLE) is a chronic patients: 7% to 13% of deaths in SLE have been attributed to CNS involvement.3-6 autoimmune disease characterized by multisystemic involvement and diverse manifestations. A large NPSLE may be seen in the context of antiphospholipid (aPL) antibodies7-9 and/or in the presence of percentage of patients demonstrate severe psychiatric and/or neurological symptoms indicating central overarching antiphospholipid syndrome (APS). The syndrome encompasses a variety of clinical maninervous system (CNS) involvement.1,2 Such involvement constitutes a leading cause of morbidity in SLE, festations. These include recurrent pregnancy loss and vascular thrombosis, which are considered to because patients with neuropsychiatric (NP) manifestations-especially those with focal symptomsbe the key manifestations in the recently developed preliminary classification criteria for APS;10 and often do not reverse their deficits during therapy.2 Neuropsychiatric systemic lupus erythematosus others such as haemolytic anemia, thrombocytopenia, livedo reticularis, and NP manifestations, the (NPSLE) also adversely affects survival in such exact relationship of which with APS still needs epithelial cells as substrate, positive titre further investigation.10-12 There is limited knowledge Á1/80, Innova), C 3 and C 4 components of compleabout which of these manifestations associate most ment by nephelometry (Beckman), autoantibodies to strongly with NPSLE. It is also unknown whether cellular antigens (SS-A/Ro, SS-B/La, U 1 RNP and Sm) additional laboratory and clinical manifestations of by counterimmunoelectrophoresis and antibodies to SLE are associated with the development of CNS dsDNA by ELISA (as previously described).18 involvement. Early reports emphasized relationships with thrombocytopenia, vasculitis and livedo reticu-
Lupus anticoagulant
laris.13,14 The independent associations of such Each patient with a prolonged partial thromboplastin manifestations with NPSLE have been difficult to study, time (PTT) underwent further studies to determine if since it has been difficult to conduct studies with an a lupus anticoagulant (LA) was present. A LA was adequate sample size.
documented if the PTT was >5 s over the laboratGiven the significant morbidity of NPSLE, it is ory's normal upper limit, there was incomplete important to determine risk factors for CNS involvecorrection on 50550 mixing with normal plasma ment in SLE. Our study was designed to determine and there was no other cause for the coagulopathy. the independence of potential risk factors for CNS The platelet neutralization test and/or dilute Russell's involvement in SLE, using an individually-matched viper venom test were used for further confirmation.19 nested case-control approach in patients from a large cohort of SLE patients.
Anticardiolipin assay
Sera from all patients were tested for anticardiolipin Methods (aCL) antibodies by an ELISA method, as previously described.20 Negative aCL titre was defined when it Patient selection and classification had a value of <4 SD above the mean of 100 SLE patients seen at the Department of the healthy subjects, low/moderate positive when levels Pathophysiology were enrolled into this nested casewere between Á4 SD and <7 SD of mean normal control study. All patients fulfilled four or more of values and high positive when Á7 SD of reference the revised criteria for SLE. 
Results
NP symptoms served as the source population for selecting the control group. NPSLE patients were
The study population consisted of 112 women and individually matched 153 for sex, age (±5 years) 16 men. Patients' mean age (SD) at SLE onset and disease duration (±5 years) to controls.
(evaluated from the first, well-described sign or Patients were also categorized according to symptom compatible with the disease) was 25.9 whether at the time of evaluation they met at least (11.6) years (range 5-60 years) and was similar in one clinical and at least one laboratory criterion of cases and controls: 26 (12) years vs. 26 (11) years, the recently adopted classification criteria for APS.10 respectively ( p=0.9). The mean (SD) time from SLE The relevant exclusions for vascular thromboses, for onset was 9.5 (8.4) years, and was also similar in those who had such events,17 were also taken into cases and controls: 9.8 (9.1) years vs. 9.4 (8.2) years, account in this categorization.
respectively ( p=0.85).
The most frequent NPSLE syndrome was cerebro-
Detection of autoantibodies vascular disease, affecting nine patients (28%).

Serological studies
Seizures were seen in eight patients (25%) while acute confusional states occurred in six (19%) and Sera were tested for the presence of antinuclear antibodies (ANA) by immunofluorescence (human psychosis in three (9%). Three more patients (9%) met the diagnostic criteria for demyelinating synwith NP disorders. All NPSLE patients were positive for ANA, with titres above 1/160. None of the SLE drome, and three patients (9%) had cranial neuropathies. All three patients who developed isolated control group had thrombocytopenia. There was also some evidence that anti-SS-B/La antibodies, as well but significant deficits in cognitive functions had sAPS. Other NP manifestations (including myelopaas low serum levels of C 3 and C 4 complement components, were related to CNS involvement. thy, chorea, major depressive episode, and GuillainBarré syndrome) were less common. Twelve patients Factors associated with NP manifestations in the univariate analysis were entered stepwise into a (38%) presented with a combination of two or more symptoms concurrently.
multiple conditional logistic regression model. As shown in Table 2 , articular manifestations and Table 1 shows the potential associations of CNS involvement with various clinical and laboratory discoid rash remained as independent protective also indicate that SLE patients with discoid lesions have a more benign disease course overall. factors, while cutaneous vasculitic lesions and arterial thromboses were independent predictors of NPSLE.
Although articular manifestations are frequent in SLE patients, in our study those patients with NP Articular manifestations reached the highest level of statistical significance, but the absolute magnitude manifestations had significantly less arthralgia or acute symmetric arthritis than patients without CNS of the associations for all these four predictors was very large. When APS was considered as a candidate involvement. Recall bias stemming from the retrospective design of the study could possibly affect the predictor, instead of its individual laboratory and clinical components, it was selected as an independstrength of this association. Nevertheless, this negative correlation agrees with the results of another ent predictor of CNS involvement in the multivariate model, and in addition, low C 4 complement level study in Greek SLE patients, in which articular manifestations tended to accompany rashes or constiwas an independent risk factor, while arthralgias/ arthritis and discoid rash were independent protective tutional symptoms, but not CNS involvement, during flares of the disease.25 Toubi et al. reported no factors with odds ratios of similar magnitude (not shown).
significant difference in the prevalence of skin manifestations and arthritis between NPSLE and SLE control patients.7 This study was conducted in a different continent, and Black patients represented
Discussion
20% of the total NPSLE group. Moreover, no exact figures were provided, so it is unknown whether any Central nervous system involvement remains a major cause of morbidity and mortality in SLE.2-6 tendency for a difference might have been present. On the other hand, West et al. showed a trend Nevertheless, the overall prevalence of major NP disorders varies among series.2,14 This is mainly due toward a smaller prevalence of articular manifestations in NPSLE group compared with that of SLE to the difficulty in defining psychiatric abnormalities and cognitive dysfunction in this disease. In some control patients.26 Thus, small sample sizes, patient selection, racial and genetic heterogeneity or differcases it is difficult to determine whether occasional NP manifestations reflect organic damage caused by ences in environmental factors which may influence disease expression, could explain discrepancies SLE, or are simply psychological reactions to the stress of having a major chronic systemic illness. In between studies in this field. Previous studies have tried to determine diagnostic an effort to provide more accurate results, we chose to exclude poorly-defined cognitive dysfunction, laboratory markers to define or detect active NPSLE, but these have yielded conflicting data, and have anxiety disorders and subtle psychiatric manifestations from our study for the purposes of defining generally failed to establish clearly defined pathogenic factors.27-29 Elevated antibody titres to dsDNA CNS disease as rigorously as possible.
Early observations suggested that vasculitis and have been proposed as helpful in identifying NPSLE patients,28 but CNS involvement can occur in the thrombocytopenia are significantly and strikingly correlated with NP involvement in SLE patients.14 Our presence of normal values of anti-dsDNA antibodies.27,29 Controversy also exists regarding the study confirms these observations. The presence of cutaneous vasculitic lesions was significantly associassociation of anti-Sm antibody with NPSLE manifestations.28,29 Increased antibody titres to dsDNA, ated with NPSLE in our best-fit multivariate model, and thrombocytopenia also was a significant risk as well as anti-Sm antibody, were not correlated with NP manifestations in our study. On the contrary, factor for such involvement, at least in univariate analysis.
low serum levels of C 3 , and particularly of C 4 complement components, were seemingly strongly The most common neuropathological finding in autopsy studies of NPSLE is a small-vessel nonassociated with NPSLE. This association probably implies an underlying relation to common pathogenic inflammatory proliferative vasculopathy characterized by hyalinization, occasionally associated with mechanisms, such as local deposition of immune complexes in blood vessel walls with subsequent occlusion, pericapillary microglia, microinfarcts and microhemorrhages.21-23 These findings differ from complement activation, resulting in vasculitis.
Vasculitis of the brain vessels has been documented those seen in chronic cutaneous lupus erythematosus, such as discoid lesions, where a perivascular monoin 7-15% of NPSLE autopsy cases. [21] [22] [23] Clinical and experimental evidence indicates that nuclear inflammatory infiltrate from activated T cells predominates.24 Different tissue pathology may aPL antibodies are significantly associated with, and may have a causative role in, vascular thromboses reflect different pathophysiological mechanisms, and this could explain the strong negative correlation and pregnancy losses.8,11,30-33 These antibodies have also been implicated as a risk factor for CNS between NPSLE manifestations and the presence of discoid lesions. Furthermore, this association may involvement in SLE,7,9 especially for manifestations The pathogenetic mechanism underlying the asso- 
